Identification of Patients Who Benefit From Bevacizumab in High-Grade Glioma-An Easy Question Turned Difficult: Treat the Scan or the Patient? Reply

Authors :: Chinot, O.L.
Taphoorn, M.J.B.
Bais, C.
Bourgon, R.
Phillips, H.S.
Abrey, L.E.
Wick, W.
Mason, W.
Henriksson, R.
Saran, F.
Nishikawa, R.
Cloughesy, T.
Neurology
CCA - Evaluation of Cancer Care
Source :: Journal of Clinical Oncology, 34(11), 1282-+. American Society of Clinical Oncology, Chinot, O L, Taphoorn, MJB, Bais, C, Bourgon, R, Phillips, H S, Abrey, L E, Wick, W, Mason, W P, Henriksson, R, Saran, F, Nishikawa, R & Cloughesy, T 2016, ' Identification of Patients Who Benefit From Bevacizumab in High-Grade Glioma-An Easy Question Turned Difficult: Treat the Scan or the Patient? Reply ', Journal of Clinical Oncology, vol. 34, no. 11, pp. 1282-+ . https://doi.org/10.1200/JCO.2015.65.2438, Journal of Clinical Oncology, 34(11), 1282
Publication Year :: 2016

Language :: English
ISSN :: 0732183X
Database :: OpenAIRE
Journal :: Journal of Clinical Oncology, 34(11), 1282-+. American Society of Clinical Oncology, Chinot, O L, Taphoorn, MJB, Bais, C, Bourgon, R, Phillips, H S, Abrey, L E, Wick, W, Mason, W P, Henriksson, R, Saran, F, Nishikawa, R & Cloughesy, T 2016, ' Identification of Patients Who Benefit From Bevacizumab in High-Grade Glioma-An Easy Question Turned Difficult: Treat the Scan or the Patient? Reply ', Journal of Clinical Oncology, vol. 34, no. 11, pp. 1282-+ . https://doi.org/10.1200/JCO.2015.65.2438, Journal of Clinical Oncology, 34(11), 1282
Accession number :: edsair.dedup.wf.001..0068941218185515d55e4509561f4dca
Full Text :: https://doi.org/10.1200/JCO.2015.65.2438

Full Text Access

Tools